beclomethasone

What the FDA Data Shows for beclomethasone

The FDA label for beclomethasone (sold under brand names such as Qvar) classifies it as a prescription-only medication in the Inhaled Corticosteroid class. Qvar Redihaler is used to treat asthma and prevent asthma attacks in adults and children 4 years and older. Official labeling lists 6 commonly reported side effects, including Mouth infection (oral candidiasis), Upper respiratory infection, Runny nose and sore throat (nasopharyngitis).

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.